Quarterly report [Sections 13 or 15(d)]

Segment Information (Tables)

v3.25.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Information
The following table is a summary of segment information for three and six months ended June 30, 2025 and 2024 (amounts in thousands):
For the three months ended For the six months ended
June 30, 2025 June 30, 2024 June 30, 2025 June 30, 2024
Net revenues
Diagnostic services $ —  $ —  $ —  $ — 
Consumer products 1,247  1,504  2,678  3,860 
Consolidated net revenue 1,247  1,504  2,678  3,860 
Cost of revenue
Diagnostic services 112  709  344  1,429 
Consumer products 401  950  1,074  2,646 
Consolidated cost of revenue 513  1,659  1,418  4,075 
Depreciation and amortization expense
Diagnostic services 205  727  539  1,528 
Consumer products 805  805  1,612  1,609 
Total Depreciation and amortization expense 1,010  1,532  2,151  3,137 
Operating and other expenses
Diagnostic services 1,560  1,138  1,728  3,162 
Consumer products 211  1,160  1,272  2,275 
Unallocated corporate 1,646  3,765  4,480  7,033 
Total operating and other expenses 3,417  6,063  7,480  12,470 
Income (loss) from operations, before income taxes
Diagnostic services (1,877) (2,574) (2,611) (6,119)
Consumer products (170) (1,411) (1,280) (2,670)
Unallocated corporate (1,646) (3,765) (4,480) (7,051)
Total loss from operations, before income taxes (3,693) (7,750) (8,371) (15,840)
Income tax (expense) benefit (779) 2,287  (779) 4,853 
Total loss from operations, after income taxes (4,472) (5,463) (9,150) (10,987)
Net loss from continuing operations $ (4,472) $ (5,463) $ (9,150) $ (10,987)
The following table is a summary of segment information as of June 30, 2025 and December 31, 2024 (amounts in thousands):
June 30, 2025 December 31, 2024
ASSETS
Diagnostic services $ 25,516  $ 26,069 
Consumer products 16,362  19,745 
Unallocated corporate 163  5,804 
Assets in discontinued operations —  11,582 
Total assets $ 42,041  $ 63,200